Blood-based biomarkers enable pre-symptomatic detection of ALS

Researchers have identified specific blood biomarkers capable of detecting Amyotrophic Lateral Sclerosis (ALS) years before clinical symptoms manifest. This discovery provides a potential window for early therapeutic intervention, though the clinical efficacy and timeline for diagnostic implementation remain to be established.